Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12-Reference-Cited by-同舟云学术

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12

Published:2003-01 Issue:1 Volume:75 Page:37-43
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Lawen Joseph G.,Davies Elizabeth A.,Mourad Georges,Oppenheimer Frederic,Molina Miguel Gonzalez,Rostaing Lionel,Wilkinson Alan H.,Mulloy Laura L.,Bourbigot Bernard J.,Prestele Hans,Korn Alexander,Girault Dani??le

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. ANTITHYMOCYTE GLOBULIN AS THE PRIMARY TREATMENT FOR RENAL ALLOGRAFT REJECTION

2. A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants

3. Relevant targets for therapy with monoclonal antibodies in allograft transplantation

4. Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts

5. Prophylactic Use of a Monoclonal Antibody (33B3.1) Directed Against Interleukin 2 Receptor Following Human Renal Transplantation

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalizations after Renal Transplantation in Children: Risk Factors, Causes, and Outcomes;Nephron;2023-11-02

2. Role of Induction in a Haplomatch, Related, Low-risk, Living-donor Kidney Transplantation with Triple Drug Immunosuppression: A Single-center Study;Indian Journal of Nephrology;2023-08-10

3. Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy;Nefrología (English Edition);2022-11

4. Risks and ways of preventing kidney dysfunction in drug-induced immunosuppression in solid organ recipients;Russian Journal of Transplantology and Artificial Organs;2022-10-20

5. Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy;Nefrología;2021-11